This study presents SynaptoGen, a differentiable extension of connectome models that links gene expression, protein-protein interaction probabilities, synaptic multiplicity, and synaptic weights, and ...

In recent days, Cathie Wood’s ARK Invest has materially increased its holdings in Beam Therapeutics, adding more than 195,000 ...

Accurately predicting complex agronomic traits remains a major bottleneck in crop breeding. This study demonstrates how ...

GE HealthCare Technologies Inc. (NYSE: GEHC) leads with 100 FDA-approved AI devices, concentrating heavily on imaging and diagnostics. Their CleaRecon DL technology sharpens cone-beam CT images using ...

A hybrid model combining LM, GA, and BP neural networks improves TCM's diagnostic accuracy for IPF, achieving 81.22% ...

Alumis is firmly in focus after announcing positive topline results from two Phase 3 trials (ONWARD1 and ONWARD2) evaluating envudeucitinib , its next-generation oral TYK2 inhibitor, in ...

Eli Lilly boasts a wide range of products that serve a vast number of therapeutic areas. LLY focuses primarily on ...

Formula 1 teams live in a world where a single misjudged flick of carbon fiber can decide a championship. Aerodynamicists are ...

Twenty-five years of research into complex systems shows why artificial intelligence will always produce errors in healthcare decisions, regardless of technological improvements or funding.

In the past decade, AI’s success has led to uncurbed enthusiasm and bold claims – even though users frequently experience its ...

What your blood pressure really says about your health – and why it’s worth tracking Your sleep score is consistently high, ...

The publication unveiled its annual selection of the most significant scientific and technological breakthroughs from the ...